Matrix metalloproteinase (MMP)-12 expression has a negative impact on sensorimotor function following intracerebral

Jennifer E A Wells1, Jeff Biernaskie, Aleksandra Szymanska

  • 1Department of Clinical Neurosciences, Faculty of Medicine, University of Calgary, 3330 Hospital Drive, Calgary, Alberta, T2N 4N1, Canada.

Insights

Matrix metalloproteinase-12 (MMP-12) worsens outcomes after intracerebral hemorrhage (ICH). MMP-12 null mice showed improved functional recovery and reduced secondary injury compared to wild-type mice following ICH.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Intracerebral hemorrhage (ICH) is a severe neurological condition with limited treatment options.
  • Matrix metalloproteinases (MMPs) are implicated in tissue remodeling and inflammation, but their specific roles in ICH are not fully understood.
  • MMP-12 was identified as a highly expressed MMP following ICH in preliminary analyses.

Purpose of the Study:

  • To investigate the role of matrix metalloproteinase-12 (MMP-12) in functional recovery and secondary injury following intracerebral hemorrhage (ICH) in a mouse model.
  • To determine if the absence of MMP-12 improves outcomes after ICH.

Main Methods:

  • Intracerebral hemorrhage was induced in wild-type (WT) and MMP-12 null mice.
  • Functional recovery was assessed using behavioral tests including forelimb reaching, tape removal, and the cylinder task.
  • Histological analysis, including Iba1 immunostaining, was performed to evaluate lesion characteristics and immune cell infiltration.

Main Results:

  • MMP-12 null mice demonstrated significantly improved functional recovery in forelimb reaching and reduced ipsilateral forelimb dependence compared to WT mice.
  • While both groups showed initial reliance on the unaffected limb, this deficit persisted longer in WT mice.
  • No significant differences in tissue sparing were observed, but WT mice showed increased recruitment of Iba1-positive cells with macrophage morphology to the lesion site.

Conclusions:

  • MMP-12 expression following ICH is detrimental and contributes to secondary injury.
  • Targeting or inhibiting MMP-12 may represent a therapeutic strategy to improve outcomes after hemorrhagic stroke.
  • This study provides the first comprehensive profiling of MMP expression in ICH and highlights MMP-12 as a key mediator of post-stroke damage.